S. Korea approves MSD’s oral COVID-19 pill for at-risk patients
SEOUL– South Korea’s drug safety agency on Wednesday granted an emergency authorization of multinational pharmaceutical company MSD’s oral drug to treat COVID-19, making it the second such pill to be…